Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-07-28

Clinical Trial Update: A Comparison of Postprandial Glucose After a MMTT, and the Metabolic Effects of Insulin Withdrawal in a Crossover Study in Subjects With Type 1 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 crossover trial evaluating postprandial glucose after a mixed meal tolerance test and metabolic effects of insulin withdrawal in adults with Type 1 di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Youngene Therapeutics Inc., Ltd. | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 2 | Status: COMPLETED